Page last updated: 2024-08-23

androstane-3,17-diol and Diabetes Mellitus, Type 1

androstane-3,17-diol has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bach, JF; Boudou, P; Cathelineau, G; Dreux, C; Feutren, G; Fiet, J; Hardy, N; Julien, R; Vexiau, P; Villette, JM	1

Trials

1 trial(s) available for androstane-3,17-diol and Diabetes Mellitus, Type 1

Article	Year
Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A. Journal of steroid biochemistry, 1990, Volume: 35, Issue:1 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstane-3,17-diol; Androstanols; Cyclosporins; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 1; Female; Hirsutism; Humans; Male; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone	1990

Article

Year

Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A.

Journal of steroid biochemistry, 1990, Volume: 35, Issue:1

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstane-3,17-diol; Androstanols; Cyclosporins; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 1; Female; Hirsutism; Humans; Male; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone

1990